KOPRAN
|
The Current P/S Ratio of KOPRAN is 2.32.
Share Price | ₹306.6 | Nov 08,2024 |
Market Cap | ₹1,477.8 Cr | |
Sales-TTM | ₹637.0 Cr | TTM-Consolidated Results |
Price/Sales | 2.32x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of KOPRAN
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹1,477.8 Cr] as on Nov 08,2024
(/) Sales [ ₹637.0 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 2.32x ]
Thus, for KOPRAN , the investors are currently willing to pay '2.32 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of KOPRAN !
The chart below summarizes the trend in P/S Ratio of KOPRAN over the last five years.
Historical PS (Price/Sales) ratio chart of KOPRAN
PS Ratio Performance Analysis for KOPRAN
- KOPRAN 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.41x.
- KOPRAN 's operated at median p/e ratio of 0.97x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, KOPRAN 's p/e ratio peaked in Mar2022 at 2.84x.
- KOPRAN 's p/e ratio hit its five-year low in Mar2020 of 0.3x.
How does KOPRAN 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
KOPRAN | 637.0 | 2.32 | 1,477.8 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 50,307.7 | 8.64 | 434,604.0 |
CIPLA LTD | 26,512.0 | 4.85 | 128,549.0 |
DR REDDYS LABORATORIES LTD | 30,084.9 | 3.56 | 106,956.0 |
ZYDUS LIFESCIENCES LTD | 20,615.3 | 4.73 | 97,468.9 |
DIVIS LABORATORIES LTD | 8,614.0 | 18.30 | 157,639.0 |
MANKIND PHARMA LTD | 11,018.0 | 9.67 | 106,527.0 |
TORRENT PHARMACEUTICALS LTD | 11,225.0 | 9.63 | 108,130.0 |
LUPIN LTD | 21,431.3 | 4.48 | 95,997.1 |
AUROBINDO PHARMA LTD | 29,718.4 | 2.59 | 77,104.3 |
ABBOTT INDIA LTD | 6,066.1 | 10.01 | 60,713.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs KOPRAN 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.32x |
Max industry PS | 18.30x |
Median industry PS | 4.85x |
Average industry PS | 7.16x |
You may also like the below Video Courses